A detailed history of Inscription Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Inscription Capital, LLC holds 4,357 shares of ABT stock, worth $504,279. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,357
Previous 4,608 5.45%
Holding current value
$504,279
Previous $478,000 3.77%
% of portfolio
0.08%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$100.07 - $118.13 $25,117 - $29,650
-251 Reduced 5.45%
4,357 $496,000
Q2 2024

Jul 17, 2024

SELL
$100.73 - $112.44 $57,919 - $64,653
-575 Reduced 11.09%
4,608 $478,000
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $265,038 - $292,723
2,420 Added 87.59%
5,183 $589,000
Q4 2023

Jan 18, 2024

BUY
$90.19 - $110.4 $22,276 - $27,268
247 Added 9.82%
2,763 $304,000
Q3 2023

Oct 17, 2023

SELL
$95.53 - $114.62 $9,553 - $11,462
-100 Reduced 3.82%
2,516 $243,000
Q2 2023

Jul 14, 2023

BUY
$100.78 - $112.29 $1,310 - $1,459
13 Added 0.5%
2,616 $285,000
Q1 2023

May 02, 2023

BUY
$96.86 - $114.01 $19,759 - $23,258
204 Added 8.5%
2,603 $263,000
Q4 2022

Feb 13, 2023

SELL
$95.06 - $111.52 $1,901 - $2,230
-20 Reduced 0.83%
2,399 $263,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $498,314 - $576,954
-5,150 Reduced 68.04%
2,419 $234,000
Q2 2022

Sep 20, 2022

BUY
$102.07 - $123.37 $551,178 - $666,198
5,400 Added 248.96%
7,569 $822,000
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $250,584 - $306,826
2,169 New
2,169 $305,000
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $971,427 - $1.07 Million
-8,327 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $880,913 - $1.04 Million
8,327 New
8,327 $965,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Inscription Capital, LLC Portfolio

Follow Inscription Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inscription Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inscription Capital, LLC with notifications on news.